Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Urolithiasis
|
February 3, 2026
Endoscopically visible Randall's plaques are an independent predictor of future stone events
Natalie Meyer, Jean Lee, Victoria Liu, et al.
European Urology Oncology
|
July 6, 2025
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era
Kevin Shee, Jonathan J Song, Janet E Cowan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 31, 2018
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER<sup>+</sup> breast cancer
Kevin Shee, Amanda Jiang, Frederick S Varn, et al.
Cancer Biomarkers : Section a of Disease Markers
|
July 6, 2020
Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer
Kevin Shee, John D Seigne, Margaret R Karagas, et al.
European Urology Focus
|
August 3, 2025
Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer
Kevin Shee, William A Pace, Andrew W Liu, et al.
The Journal of Urology
|
September 6, 2022
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort
Kevin Shee, Samuel L Washington, Janet E Cowan, et al.
European Urology Oncology
|
January 31, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer
Kevin Shee, William A Pace, Jonathan J Song, et al.
European Urology Focus
|
May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort
Kevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
European Urology Oncology
|
May 7, 2025
Multivitamin Use After Prostate Cancer Diagnosis Is Associated with Lower Risk of Recurrence: A Prospective Cohort Study from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)
Kevin Shee, Benjamin E Cedars, Lufan Wang, et al.
The Journal of Experimental Medicine
|
February 14, 2018
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer
Kevin Shee, Wei Yang, John W Hinds, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Urolithiasis
|
February 3, 2026
Endoscopically visible Randall's plaques are an independent predictor of future stone events
Natalie Meyer, Jean Lee, Victoria Liu, et al.
European Urology Oncology
|
July 6, 2025
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era
Kevin Shee, Jonathan J Song, Janet E Cowan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 31, 2018
Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER<sup>+</sup> breast cancer
Kevin Shee, Amanda Jiang, Frederick S Varn, et al.
Cancer Biomarkers : Section a of Disease Markers
|
July 6, 2020
Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer
Kevin Shee, John D Seigne, Margaret R Karagas, et al.
European Urology Focus
|
August 3, 2025
Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer
Kevin Shee, William A Pace, Andrew W Liu, et al.
The Journal of Urology
|
September 6, 2022
Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort
Kevin Shee, Samuel L Washington, Janet E Cowan, et al.
European Urology Oncology
|
January 31, 2026
A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer
Kevin Shee, William A Pace, Jonathan J Song, et al.
European Urology Focus
|
May 15, 2025
Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort
Kevin Shee, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.
European Urology Oncology
|
May 7, 2025
Multivitamin Use After Prostate Cancer Diagnosis Is Associated with Lower Risk of Recurrence: A Prospective Cohort Study from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)
Kevin Shee, Benjamin E Cedars, Lufan Wang, et al.
The Journal of Experimental Medicine
|
February 14, 2018
Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer
Kevin Shee, Wei Yang, John W Hinds, et al.
Page
of 7